chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Arm and head hurt badly; Sick to her stomach; Lost most of the taste and smell; Lost most of the taste and smell; Weird taste in her mouth; Headache; Swelling in her throat; Injection site pain; Muscle pain; Injection site swelling and redness; Injection site swelling and redness; Swollen lymph node; This is a spontaneous report from a contactable consumer. A 47-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number/expiration date not reported), via an unspecified route of administration, on 24Jan2021 at a single dose for COVID-19 immunization. Medical history included asthma from an unknown date. Concomitant medications were not reported. It was reported that the patient got the COVID-19 vaccine shot on 24Jan2021. When she sat there for 15 minutes, she got a weird taste in her mouth and got a headache. At 2 PM she still had a headache and she lost most of the taste and smell; at 4 pm she was sick to her stomach; by 5:15, her arm and head hurt badly, the taste in her mouth was like super weird but it was not exactly metallic taste it was weird bizarre taste she never had before. Her smell came back. She was extremely nauseated and had a bad headache. She stated that all of her symptoms were gone away except the swelling in her throat. She further stated she called the hospital and stated she got injection site pain, headache, and muscle pain. She also got injection site swelling and redness, nausea, swollen lymph node and a headache and the weirdest part that really bothered her was the strange taste in her mouth. She got some of the smell and taste back and now it's gone; it's really bizarre like the injection site pain, the headache everything was gone literally gone. The only things that was still hanging on was her lymph nodes and throat. The second due dose of vaccine was on 14Feb2021. The patient has not recovered from swelling in her throat and swollen lymph node, and has recovered from other events.  Information on the lot/batch number has been requested.
prolonged gen sz followed y prolonged apnea p/vax given;required assisted ventilation x 10hr;no fever @ time of sz;
This spontaneous report was received from a registered nurse refers to a patient of unknown age. The medical history, concurrent condition and concomitant medications were not reported. On an unknown date in 2006, the patient was vaccinated with VARIVAX (Merck) (lot# not reported) dose 1. On an unknown date, the patient experienced negative titers. On 31-MAR-2016, the patient was vaccinated with VARIVAX (Merck) (lot# not reported) dose 2. The outcome of the event was unknown. Additional information has been requested.
Caller mentioned she opened a box of Prevnar 20 and she noticed there is a brown small precipitant in the vaccine; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team and product quality group.  A patient (no qualifiers provided) received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), as dose number unknown, single (Lot number: GN1898) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LIQUID PRODUCT PHYSICAL ISSUE (non-serious), outcome "unknown", described as "Caller mentioned she opened a box of Prevnar 20 and she noticed there is a brown small precipitant in the vaccine".  Additional information: Caller mentioned she opened a box of Prevnar 20 and she noticed there is a brown small precipitant in the vaccine. She said it is not a lot, but there is a small brown precipitant. She wants to know if this is common.
Pt presented with massive swelling on 10/6 post vaccine administration on 10/5. She could not lift her arm. On 10/7 she presented in the pharmacy and c/o swelling, redness, tenderness and warmth at site of injection. Swelling is approx the size of my palm. Pt was provided BENADRYL. Redness subsided after taking BENADRYL.
Rash - developed on night of vaccine and then got worse. It has spiked at about day 13 after the shot, large, painful hives, concentrated mostly on extremities (forearms, hands, feet, lower leg) but also on neck, face torso and roof of mouth. Benadryl and Allegra can help but in the worst state, even those just barely keep a lid on it. Still progressing.
I had been menstruating  for 10 days (and I haven't stop), when I usually do it for 4 days. Isn't a heavy bleeding but still I'm still bleeding.
At 7:00 PM I noticed a feeling of slight prickling in my arms, legs, and neck. I thought nothing of this until around 7:30 where I began to have extreme chills and a headache. Around 9:00, I tried to get some water and I was too dizzy to walk at any normal pace. I took my temperature and it read at 101.9F. I proceeded to take ibuprofen, drink lots of water (about 80 oz that night), and go to sleep as best as I could.
p/pt recvd DTP/OPV pt fussed, held breath, became cyanotic, eyes rolled back & passed out lasted approx 30-sec-1min;
experienced increased heart rate; shortness of breath; skin rash; redness; This is a spontaneous report from a non-contactable consumer. This report was received via a sales representative. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown) via an unspecified route of administration on an unspecified date in Dec2020 at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient had no known previous allergies or adverse reactions to vaccines. The female healthcare worker experienced increased heart rate, shortness of breath, skin rash and redness 10 minutes after vaccination in Dec2020. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
maternal exposure during pregnancy; Sore arm  after getting the vaccine; This spontaneous prospective pregnancy case was reported by a health care professional and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy) and VACCINATION SITE PAIN (Sore arm  after getting the vaccine) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 26-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy) and VACCINATION SITE PAIN (Sore arm  after getting the vaccine). On 26-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (maternal exposure during pregnancy) had resolved. At the time of the report, VACCINATION SITE PAIN (Sore arm  after getting the vaccine) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not reported. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 04-Feb-2021: Internal review on 19JUL2021 resulted in updates to pregnancy details.
This spontaneous report was received from a physician, via company representative, referring to a child of unknown gender and unknown age (age reported between 2 to 3-year-old). Information regarding the patient's medical history, concurrent conditions or concomitant medications was unknown. On an unknown date, the patient was vaccinated with the first dose of M-M-R II for prophylaxis (dose, route of administration, anatomical location, lot number and expiration date were not reported). On an unknown date in 2019 (reported as within the last two weeks), after receiving M-M-R II the patient developed measles. It was unknown if medical attention was sought, if any laboratory diagnostic was performed or if the patient received treatment. At the time of the report, the outcome of measles was unknown. The reporter did not provide causality assessment between the events and vaccination with M-M-R II. Upon internal review the event measles was determined to be medically significant.
Starting  4/8/21, the day after the injection, I had pain in my neck, upper back, both arms, and lower back. Today is 4/15/21 and I am still having pain in my left arm and shoulder. Starting today 4/15/21, I have a red irregularly shaped blotch on my left chest area. It does not hurt or itch. Ibuprofen and warm compresses seem to help the pain. The compresses have not been hot enough to cause the redness. I've had no fever, dizzyness or other symptoms I see described for a Shingrix shot. This was my 1st dose.   Note that I had the Pfizer Covid 19 vaccination on 2/9/21 and 3/3/21 in left arm and no side effects except sore arm and fatigue for a few days.
Sleepy; loss of appetite; slight fever; chills; This spontaneous case was reported by a patient and describes the occurrence of SOMNOLENCE (Sleepy), DECREASED APPETITE (loss of appetite), PYREXIA (slight fever) and CHILLS (chills) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A, 031L20A and 039F21A) for COVID-19 prophylaxis.     The patient's past medical history included Acid reflux (esophageal) (Severe). Concurrent medical conditions included Asthma and Blood pressure high. Concomitant products included AMLODIPINE, LOSARTAN, EXEMESTANE, OMEPRAZOLE and ATORVASTATIN for an unknown indication.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Feb-2021, the patient experienced SOMNOLENCE (Sleepy), DECREASED APPETITE (loss of appetite), PYREXIA (slight fever) and CHILLS (chills). At the time of the report, SOMNOLENCE (Sleepy), DECREASED APPETITE (loss of appetite), PYREXIA (slight fever) and CHILLS (chills) outcome was unknown.            On 09 Feb 2021, the patient had experienced the events of slight fever, sleepy, loss of appetite, and chills after Dose 1 of Moderna COVID-19 vaccine. On 09 Mar 2021, the patient had experienced the events of slight fever, sleepy, loss of appetite, and chills after Dose 2 of Moderna COVID-19 vaccine. On 04 Nov 2021, the patient had experienced the events of slight fever, sleepy, loss of appetite, and chills after first booster dose of Moderna COVID-19 vaccine.  No treatment drug information was provided.   This case was linked to MOD-2022-661435 (Patient Link).
After injection felt achiness through entire back, around 5p had chills, had tingling in fingertips in the evening, had headache, fever of 102.8. Took TYLENOL and Ibuprofen which decreased fever to 100.1. States next day still had fever and redness with soreness at injection site.
vaccine was initially stored in the refrigerator - 05Jan2023 and administered on 06Feb2023; No adverse event; administered doses of the bivalent booster which were beyond the 30 day BUD; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered doses of the bivalent booster which were beyond the 30 day BUD), PRODUCT STORAGE ERROR (vaccine was initially stored in the refrigerator - 05Jan2023 and administered on 06Feb2023) and NO ADVERSE EVENT (No adverse event) in an 81-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 022H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 06-Feb-2023 at 1:34 AM, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 06-Feb-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered doses of the bivalent booster which were beyond the 30 day BUD). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vaccine was initially stored in the refrigerator - 05Jan2023 and administered on 06Feb2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered doses of the bivalent booster which were beyond the 30 day BUD), PRODUCT STORAGE ERROR (vaccine was initially stored in the refrigerator - 05Jan2023 and administered on 06Feb2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        The action taken with mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) was unknown.   For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (administered doses of the bivalent booster which were beyond the 30 day BUD) and PRODUCT STORAGE ERROR (vaccine was initially stored in the refrigerator - 05Jan2023 and administered on 06Feb2023).    No concomitant medication were reported.  It was reported that there 2 doses were administered on 06Feb2023 and 2 doses on 07Feb2023. The vaccine was initially stored in the refrigerator on 05Jan2023.  No treatment medication were reported.    This case was linked to US-MODERNATX, INC.-MOD-2023-709192, US-MODERNATX, INC.-MOD-2023-710235, US-MODERNATX, INC.-MOD-2023-710238 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-710235:Patient   US-MODERNATX, INC.-MOD-2023-709192:Patient - Female US-MODERNATX, INC.-MOD-2023-710238:Patient - Male
Hives on both arms about 5 hours after second injection. Spread to my legs 5 days later; This is a spontaneous report from a contactable other healthcare professional (patient). A 57-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3249 and expiration date not provided), via an unspecified route of administration in the left arm on 27Jan2021 13:45 at a single dose for COVID-19 immunization. The patient's medical history was not reported. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has no allergies to medications, food or other products. Concomitant medications included metformin, colecalciferol (VITAMIN D), biotin and multivitamins. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140) on 06Jan2021 13:45 in the left arm at the age of 57 years old for Covid-19 Immunization. On 27Jan2021 18:00, the patient experienced hives on both arms about 5 hours after second injection which spread to the patient's legs 5 days later. The patient saw her PCP today and she felt it was related to vaccine. The adverse event resulted in Doctor or other healthcare professional office/clinic visit. Treatment received for the adverse event included antihistamine. The outcome of the event was not recovered. The reporter assessed the event as non-serious.
Injection site soreness; Rash all over upper body since injection; Very itchy; This is a spontaneous report from a contactable consumer (patient). A 58-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EL9262), via an unspecified route of administration, administered in Arm Left on 10Feb2021 13:15 (at the age of 58-year-old) as dose number unknown, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines in 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient had been tested for COVID-19. Patient had no known allergies. Patient reported that injection site soreness 1 week. Rash all over upper body since injection. 12 days now. Very itchy (11Feb2021 12:00 AM). Patient visited doctor or other healthcare professional office/clinic. There was no treatment for the events. The patient underwent lab tests and procedures which included COVID test/Nasal Swab: negative on 12Feb2021. The clinical outcome of events was not recovered.  Follow-up attempts are completed. No further information is expected.
2 days of spreading erythema & induration at vaccination site, with size of erythema 12.7 cm x 8.2 cm after two days. Treated with TYLENOL & BENADRYL.
I received my Pfizer vaccine on 9/9/21 and 9/30/21.  I developed what I thought was a rash on both of my lower legs on 10/4 that progressively got worse despite cortisone cream started on 10/6 and Clobatesol topical started on 10/8.  I had another spot on my chest and upper right thigh.  I was seen on 10/12, had a CBC drawn and was started on Prednisone.  I was seen by Dermatology (the following morning, 10/13) and one of the lesions was biopsied..  I was on Prednisone for 15 days total (40 mg x 5 days, 20 mg x5 days and 10 mg x 5 days).  The biopsy came back as Lichen Planus, an immune response to receiving the vaccination.
body aches, fatigue, off and on for 3 days, lots of sleeping slight chills for a few hours on day 2
Hardly adverse. Reported lifting of 'brain fog' and improved ability to spell and recall words; This is a spontaneous report received from a contactable reporter(s) (Physician).  A female patient (not pregnant) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "unknown", described as "Hardly adverse. Reported lifting of 'brain fog' and improved ability to spell and recall words". Therapeutic measures were not taken as a result of therapeutic response unexpected.  The reporter considered "hardly adverse. reported lifting of 'brain fog' and improved ability to spell and recall words" not related to bnt162b2.  Additional information: Reporter states she previously called to report on an acquaintance about her Covid vaccine, it was hardly an AE, she reported that she was able to think more clearly which was a benefit. Caller states she received a multipage questionnaire and has tried calling her acquaintance and left phone messages for her but has no information to provide. Caller is asking what she should do now as she has no further information to provide. Caller states will this be the next Viagra. States she has no idea if it was after the 1st or 2nd dose or how long after but that she was happy. It was unknown, if patient received any other vaccines within 4 weeks prior to covid vaccine. It was unknown, if patient was tested positive for covid 19 prior to vaccination and post vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Continual headaches, fatigue, shortness of breath, joint pains, pain in hands and feet, numbness (mild) all over body
Information has been received from a physician concerning a female who was vaccinated with 0.5 ml first dose of GARDASIL vaccine (yeast). Subsequently the patient developed hives that lasted longer than a week. She was treated with diphenhydramine hydrochloride (BENADRYL) but the hives did not go away. Additional information has been requested. This is iin follow-up to report (s) previously submitted on 11/14/2007.  Initial and follow up information has been received from a physician concerning a 26 year old female who was vaccinated on 24-SEP-2007 with a 0.5 ml first dose of GARDASIL.  Concomitant medication included AMBIEN.  Subsequently within a 1- days, on 26-SEP-2007, the patient developed red bumps and was itchy (previous reported as hives).  On 04-OCT-2007 she still had symptoms and was treated with BENADRYL.  She was given a prescription for ALLEGRA 60 mo bid.  The patient believed that she had a reaction to AMBIEN not the GARDASIL.  The  itch stopped after stopping AMBIEN.  As of 10-OCT-2007 she was recovered.  Additional information is not expected.
Narrative:  Patient had received a covid vaccine EUA (J&J) on 4/1/2021. On 8/23/2022 patient was admitted to hospital 8/19/2022 for COVID+ symptoms. Pt was determined to be COVID +. Pt died on 8/24/2022 at hospital. No information available if Covid treatment medications were given. Covid vaccine EUA (J&J) failure. --Location of Death--Medical Center Primary Medical Diagnosis: Ileostomy Status(ICD-10-CM Z93.2) COVID Infection
Arm Pain; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The case was reported for the pharmacist's mother. The patient experienced arm pain for a couple of months. The reporter did not consent to follow up. This case was linked with case US2019080686 (reporter's case) reported by the same reporter.
Information has been received from a physician concerning an 18 year old female with allergies who on 20-AUG-2007 was vaccinated intramuscularly with her first dose of Gardasil (lot# not reported). Concomitant therapy included ORTHO TRI-CYCLEN and ALLEGRA. On 23-NOV-2007 the patient was vaccinated intramuscularly with her second dose of Gardasil (lot# not reported). On 26-NOV-2007 the patient experienced a single hive near her eye. The patient contacted the office and was prescribed SUDAFED. Subsequently, the patient recovered from a single hive near her eye after one dose of pseudoephedrine hydrochloride. The patient did mention that she ate shrimp on 26-NOV-2007. There was no adverse reaction after the first dose of Gardasil. Additional information has been requested.
12 hours after injection (Tdap) awoke to whole body shaking, mouth felt "locked shut" x 10 minutes. Pt. layed down had 2nd episode of "body tingling". Lasted 3 minutes. 1 hour later body felt tense/light, sweating. Pt. did not check temp. Took TYLENOL.
pt recvd vax & became pale & limp w/in 1/2 hr;